Europe gives go ahead to market Ebola vaccine

By |november 12th, 2019|Democratic Republic of Congo, Ebola, European Medicines Agency, Guinea, Liberia, News, Sierra Leone, vaccines|

The European Union authorised the marketing of a vaccine against Ebola on Monday (11 November), permitting the first wider commercial use of a protection that has helped stem an outbreak in DR Congo.

Komentarji so izklopljeni za Europe gives go ahead to market Ebola vaccine

Brexit turns EU into landlord in the City of London

By |februar 21st, 2019|Amsterdam, Brexit, City of London, EMA, EMA relocation, European Medicines Agency, News|

The European Medicines Agency is looking to sublet its former headquarters in the financial district of London, after a British court ruled on Wednesday (20 February) that it cannot break its lease despite the UK’s withdrawal from the EU.

Komentarji so izklopljeni za Brexit turns EU into landlord in the City of London

European Medicines Agency launches review of recalled heart drug

By |avgust 3rd, 2018|blood pressure, cancer, European Medicines Agency, NDMA, News, Zhejiang Huahai|

The European Medicines Agency (EMA) said Thursday it is conducting a review of the health effects on patients of a widely used blood pressure medication recalled around the world last month.

Komentarji so izklopljeni za European Medicines Agency launches review of recalled heart drug

EU drugs agency to see 30% staff losses over Brexit move

By |avgust 1st, 2018|Amsterdam, Brexit, EU agencies, European Medicines Agency, News|

The European Medicines Agency (EMA) is to scale back operations further as it copes with higher than expected staff losses, triggered by the watchdog's forced relocation from London to Amsterdam because of Brexit.

Komentarji so izklopljeni za EU drugs agency to see 30% staff losses over Brexit move

Health care risks being forgotten in Brexit talks, industry warns

By |februar 22nd, 2018|Big pharma, Brexit, European Medicines Agency, News, patients, public health|

Health risks being forgotten in Brexit negotiations, potentially delaying the availability of new medicines and imposing large costs on manufacturers, public health leaders have warned.

Komentarji so izklopljeni za Health care risks being forgotten in Brexit talks, industry warns

Italian pharma chief: Dutch EMA bid ‘may have misled’ the Commission

By |februar 7th, 2018|Brexit negotiations, EMA, EMA relocation, European Medicines Agency, News|

The smooth transition of the EU drug agency from London to Amsterdam is threatened by delays in the Netherlands, whose bid to win the agency may have been misleading, a top representative of Italian pharmaceuticals told EURACTIV.com.

Komentarji so izklopljeni za Italian pharma chief: Dutch EMA bid ‘may have misled’ the Commission

Dutch official: The EU drug agency transition has been ‘by the book’

By |januar 31st, 2018|European Medicines Agency, News|

The preparations for relocating the European Medicines Agency to the Netherlands next year are underway and on schedule, a senior Dutch government official in the EU told EURACTIV.com on Wednesday (31 January), after recent media reports suggested that...

Komentarji so izklopljeni za Dutch official: The EU drug agency transition has been ‘by the book’

Italy cries foul over temporary accommodation of EU Medicines Agency

By |januar 30th, 2018|Amsterdam, Brexit, EMA, European Medicines Agency, Italy, Netherlands, News, relocation of agencies|

Dutch officials and the head of the European Medicines Agency (EMA) sought yesterday (29 January) to allay any jitters among the agency's 900 London-based staff who are being asked to move to Amsterdam because of Britain's departure from the EU.

Komentarji so izklopljeni za Italy cries foul over temporary accommodation of EU Medicines Agency

Stakeholders call for more transparent meetings between pharma and EMA

By |januar 12th, 2018|EMA, EMA relocation, European Medicines Agency, News|

Public health organisations and EU lawmakers say the closed-door meetings before the submission of a new drug between the pharma industry and the European Medicines Agency (EMA), a key player in the continent’s healthcare industry, should be more transparent.

Komentarji so izklopljeni za Stakeholders call for more transparent meetings between pharma and EMA

Pharma firms face multi-million Brexit bill, MPs warned

By |december 20th, 2017|Brexit, European Medicines Agency, News, pharmaceuticals, Tarrifs|

Pharmaceutical companies face a multi-million euro bill in regulatory costs regardless of whether the UK reaches a ‘soft’ or ‘hard’ Brexit deal with the European Union, industry leaders warned on Tuesday (19 December).

Komentarji so izklopljeni za Pharma firms face multi-million Brexit bill, MPs warned